John R. Murphy - 19 Jan 2023 Form 3 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role: Director
Signature: /s/ John R. Murphy
Issuer symbol: CVKD
Transactions as of: 19 Jan 2023
Net transactions value: $0
Form type: 3
Filing time: 19 Jan 2023, 19:20:41 UTC
Previous filing: 04 Aug 2022
Next filing: 24 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CVKD	Common Stock						50,000	19 Jan 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CVKD	Stock Options							19 Jan 2023	Common Stock	100,000	$0.6400	Direct
holding	CVKD	Convertible Promissory Note							19 Jan 2023	Common Stock	514,792	$1.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Mr. Murphy is the holder of a convertible promissory note in the principal amount of $500,000 that is convertible into 514,792 shares of common stock issuable upon consummation of the initial public offering of Cadrenal Therapeutics, Inc., based on an as adjusted conversion price of $1.00 per share.